Why the study?
Can the Amplatzer multifenestrated atrial septal defect occluder device be used to successfully close a large postinfarction ventricular septal defect?
Can the Amplatzer multifenestrated atrial septal defect occluder device be used to successfully close a large postinfarction ventricular septal defect?
This case report demonstrates the feasibility of using the Amplatzer multifenestrated atrial septal defect occluder for transcatheter closure of a postinfarction ventricular septal defect with peculiar anatomical characteristics.
May support off-label device use in select postinfarction VSDs; leaves open need for prospective validation before broader adoption.
Rupture of the interventricular septum is a rare and life-threatening complication of acute myocardial infarction. Postmyocardial infarction, ventricular septal defect is associated with very high morbidity and mortality. The therapy of this complication is the surgical closure. The Amplatzer occluder is currently used to close percutaneously atrial septal defect, patent foramen ovale, and selected congenital ventricular septal defect. Few cases are described regarding transcatheter closure of a postinfarction ventricular septal defect. Here we report a case of a large postinfarction ventricular septal defect successfully closed with Amplatzer multifenestrated atrial septal defect occluder device because of its peculiar anatomical characteristics.
No takes yet. Share an insight, caveat, or question.
Giombolini et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: